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Marked by incomplete division of the embryonic forebrain, holoprosencephaly is one of the most 
common human developmental disorders.  Despite decades of phenotype driven research, 80-
90% of aneuploidy-negative holoprosencephaly individuals with a probable genetic etiology do 
not have a genetic diagnosis.  Here we report holoprosencephaly associated with variants in the 
two X-linked cohesin complex genes, STAG2 and SMC1A, with loss-of-function variants in 10 
individuals and a missense variant in one.  Additionally, we report four individuals with variants 
in the cohesin complex genes that are not X-linked, SMC3 and RAD21.  Using whole mount in 
situ hybridization, we show that STAG2 and SMC1A are expressed in the prosencephalic neural 
folds during primary neurulation in the mouse, consistent with forebrain morphogenesis and 
holoprosencephaly pathogenesis.  Finally, we found that shRNA knockdown of STAG2 and 
SMC1A causes aberrant expression of HPE-associated genes ZIC2, GLI2, SMAD3, and FGFR1 
in human neural progenitor cells.  These findings show the cohesin complex as an important 
regulator of median forebrain development and X-linked inheritance patterns in 
holoprosencephaly. 
Keywords 




Holoprosencephaly (HPE) is defined by incomplete division of the embryonic forebrain.  While 
occurring in approximately 1 in 10,000 live births, HPE is estimated to occur in 1 in 250 
embryos, making it one of the most common human developmental abnormalities (Matsunaga 
and Shiota, 1977).  The most common cause is trisomy 13 which accounts for roughly 50% of all 
cases (Kruszka, 2018).  Over the last two decades, four principal genes have been associated 
with HPE:  SHH at 7q36.3, ZIC2 at 13q32.3, SIX3 at 2p21, and TGIF1 at 18p11.31.  These 4 
genes have been the mainstay for genetic testing in individuals with HPE and normal karyotypes 
(Pineda-Alvarez et al., 2010; Kruszka et al., 2018).  At least 10 other genetic loci have 
associated with HPE, but at a lower prevalence (Kruszka et al., 2018).  SHH, SIX3, ZIC2 and 
TGIF1 account for only a fraction of the genetic etiology in individuals with normal karyotypes. 
In a recent next generation sequencing study of 257 individuals with HPE, deleterious variants in 
SHH was most common in 5.8% of the HPE cohort, ZIC2 at 4.7% , SIX3 at 2.7% and no 
deleterious variants in TGIF1 (Dubourg et al., 2016); collectively, these four genes accounted for 
13.2% of the etiology in these individuals.  With the introduction of whole exome sequencing, 
driver mutations in new genes including FGFR1 and CNOT1 are being found (Simonis et al., 
2013; De Franco et al., 2019; Kruszka et al., 2019).  To expand the genetic etiology of HPE and 
uncover novel regulators of forebrain development, we have applied whole exome sequencing 
(WES) to 277 probands with HPE and both their parents (trios), if available.   
 
We initially identified loss of function variants in cohesin complex genes in 5 of 277 (1.8%) 
individuals in our holoprosencephaly cohort at the National Institutes of Health (NIH).  Through 
our research network and GeneMatcher (Sobreira et al., 2015), we identified 10 other individuals 
with holoprosencephaly and variants in cohesin complex genes.  Collectively, these 15 
individuals with HPE have 13 loss of function (LOF) variants, one in-frame deletion, and one 
pathogenic missense variant distributed across the four cohesin complex genes SMC1A [MIM: 
300040, STAG2 [MIM: 300826], SMC3 [MIM: 606062], and RAD21 [MIM: 606462].  The 
majority of cases (11/15) are females with variants in the X-linked genes SMC1A and STAG2.  
Cohesin is a highly conserved multiprotein complex with SMC1A, SMC3, RAD21 and 
STAG1/STAG2 as its subunits in mammals (Brooker and Berkowitz, 2014).  This complex 
forms a ring structure that is involved in sister chromatid cohesion during DNA replications.  
Additional roles of this complex include transcription regulation and DNA repair (Mehta et al., 
2013).  Mutations in the cohesin complex and its regulators have been associated with four 
human genetic syndromes:  Cornelia de Lange syndrome (CdLS) caused by variants in NIPBL 
(Krantz et al., 2004), SMC1A (Musio et al., 2006), SMC3 (Deardorff et al., 2007), RAD21 
(Deardorff et al., 2012b), BRD4 (Olley et al., 2018), and HDAC8 (Deardorff et al., 2012a); 
Roberts syndrome caused by mutations in ESCO2 (Gordillo et al., 2008), CHOPS syndrome 
(Cognitive impairment and coarse facies, Heart defects, Obesity, Pulmonary involvement, and 
Short stature and skeletal dysplasia) associated with  AFF4 variants (Izumi et al., 2015); and, 
Chronic Atrial and Intestinal Dysrhythmia caused by mutations in SGOL1 (Chetaille et al., 
2014).  The cohesin complex genes that we associate with holoprosencephaly (STAG2, SMC1A, 
SMC3, and RAD21) are intolerant of variation based on the Genome Aggregation Database 
(gnomAD) constraint metric of observed/expected loss of function (o/e) values (Lek et al., 
2016).  Values less than 0.35 (o/e) are considered under selection against LOF 
(https://gnomad.broadinstitute.org) and the cohesin complex genes were well below this 
threshold:  STAG2 0.02 (90%CI, 0.1-0.09), SMC1A 0.0 (90%CI, 0.0-0.06), SMC3 0.0 (90%CI, 
0.0-0.04), and RAD21 0.1 (90%CI, 0.04-0.26). 
 
Materials and methods 
Subjects and clinical phenotyping 
The individuals and families with HPE in this study were recruited from multiple clinical 
genetics centers internationally.  Within the participating institutions, the phenotype was 
evaluated by clinical exam by the authors of this study and brain imaging (MRI or CT) or 
autopsy to confirm holoprosencephaly.  The study was approved by National Human Genome 
Research Institute Institutional Review Board (IRB) and the ethical committee of the patient’s 
local institutions.  The subjects’ consents were obtained according to the Declaration of Helsinki. 
 
DNA Sequence analysis 
Sanger sequencing 
With the goal of new gene discovery, probands were prescreened for four common genes known 
to cause HPE:  SHH [MIM 600725]) on 7q36, ZIC2 [MIM 603073] on 13q32, SIX3 [MIM 
603714] on 2p21, and TGIF1 [MIM 602630] on 18p11.3 using Sanger sequencing 
(Supplementary Methods).  Novel variants found in this study by whole exome sequencing were 
also confirmed with Sanger sequencing. 
 
Whole exome sequencing 
Whole exome sequencing (WES) was performed at NISC on the individuals from the NIH HPE 
cohort (see Supplementary Methods).  The remaining individuals were sequenced at six other 
academic and commercial laboratories (laboratory locations listed in Supplementary Table 4).  
All WES results were verified by Sanger sequencing.  Stringent variant filtering of the NIH 
cohort included:  (1) de novo inheritance of variants in genes known to be intolerant of variation 
(Lek et al., 2016), (2) absence in the ExAC data base (Lek et al., 2016), and (3) Combined 
Annotation-Dependent Depletion (CADD) scores above 20 (Kircher et al., 2014).   
 
Mouse embryo in situ hybridization 
Genes that contribute to median forebrain morphogenesis and HPE pathogenesis are expressed in 
the prosencephalic neural folds that give rise to the forebrain during primary neurulation 
(Roessler, 2018).  We therefore examined expression of Stag2 and Smc1a by in situ 
hybridization (ISH) on mouse embryos at GD8.25 (Supplementary methods), a stage 
representing early neurulation and within the critical period for HPE genesis (Heyne et al., 
2015a).  ISH was conducted as previously described and analysis was limited to the 
prosencephalic regions of the neural fold from which the forebrain will develop (Everson et al., 
2017).  This study was conducted in strict accordance with the recommendations in the Guide for 
the Care and Use of Laboratory Animals of the National Institutes of Health.  The protocol was 
approved by the University of Wisconsin-Madison School of Veterinary Medicine Institutional 
Animal Care and Use Committee (protocol number 13–081.0).  CD-1 mice (Mus musculus) were 
purchased from Charles River and C57BL/6J mice from The Jackson Laboratory.  Timed-
pregnancies were established as previously described (Heyne et al., 2015b).  Embryos were 
dissected at GD8.25 and fixed overnight in 4% PFA.  In situ hybridization (ISH) was conducted 
on whole C57BL/6J embryos or 50 μm sections cut from CD-1 embryos with a vibrating 
microtome in the transverse plane along the anterior-posterior axis.  ISH was conducted as 
previously described (Everson et al., 2017). 
 
Gene expression studies in human neural progenitor cells 
In order to test the hypothesis that variation in cohesin genes, specifically STAG2 and SMC1A, 
perturb known forebrain developmental pathways, we measured selected gene expression 
associated with these pathways.  First, knockdown of STAG2 and SMC1A with shRNA was 
performed on human neural stems cells (Supplementary Methods; Figure S1).  Known HPE 
pathways were analyzed at the gene expression level with RT-qPCR of SHH, SIX3, FGFR1, 
GLI2, ZIC2, GLI2, SMAD3 and DISP1 genes. 
 
Data availability 




Patients:  phenotype and genotype 
We assembled 277 individuals with HPE in our NIH cohort (135 trios and 142 singletons); the 
cohort characteristics are shown in Supplementary Table 1.  In the four classic HPE genes, 
pathogenic variants were found in 33 (11.9%) individuals:  ZIC2 was most common with 15 
(5.4%) variants, followed by SHH 9 (3.2%), SIX3 8 (2.9%), and TGIF1 1 (0.4%).  For these four 
genes, Supplementary Table 2 lists each variant, HPE subtype and inheritance pattern.  In our 
HPE cohort of 277 individuals at NIH, four females had truncating mutations (four nonsense and 
one splice site) in the cohesin complex genes STAG2 and SMC1A on the X chromosome, and one 
proband had a nonsense variant in RAD21 (Table 1-4).  Another four LOF variants in STAG2 in 
females, two LOF variants and one missense variant in SMC1A all in females, a LOF in RAD21, 
and an in-frame deletion in SMC3 were found through our group’s holoprosencephaly network, 
DECIPHER (Firth et al., 2009) and GeneMatcher (Sobreira et al., 2015) (Table 1; 
Supplementary Case Reports). 
 
STAG2 
The phenotypes of four of six patients with STAG2 pathogenic variants in the present study 
included the most severe forms of HPE:  alobar HPE with cyclopia, alobar without cyclopia, and 
semilobar HPE (patients 1-4 Table 1-2).  The other two patients with STAG2 variants had milder 
forms of HPE (patients 5-6 Table 1): patient 5 had microform HPE which is characterized by 
midline clefting, hypotelorism and depressed nasal bridge without brain anomalies (Figure 1B), 
and patient 6 is classified with septo-optic dysplasia type of HPE (Hahn et al., 2010) based on 
ophthalmology exam showing optic nerve hypoplasia and MRI findings of mildly dysmorphic 
neurohypophysis.  In Table 2, we compare the genotypes and phenotypes of the 6 cases in the 
present study with 6 cases with LOF variants from the medical literature (Mullegama et al., 
2017; Aoi et al., 2019; Yuan et al., 2019).  Overlapping clinical features of the 6 individuals in 
the present study and the 6 individuals in the medical literature include two of the six cases from 
the medical literature with HPE:  patient 1 from Aoi et al. has a structural brain malformation 
consistent with HPE, and patient 3 from Yuan et al. has the microform HPE subtype.  Microform 
HPE is the least severe form of HPE characterized by midline defects such as a single central 
incisor without the typical defect in brain cleavage.  Additionally,  three of the four cases in the 
medical literature have midline brain malformations including HPE as noted above, agenesis of 
the corpus callosum, and dysgenesis of the corpus callosum.  Most of the present study and the 
cases in the medical literature have vertebral anomalies:  6 of 7 that reported spine anomalies.  
Vertebral anomalies are not part of the clinical features associated with CdLS, but are commonly 
found in individuals with variants in SMC3 and RAD21 (Kline et al., 2018).  Also, 7 of 9 total 
had congenital heart disease.  All LOF STAG2 variants in the medical literature are de novo; 
interestingly, in the present study, patient 4, (1/5) is inherited maternally which may be explained 
by skewed X-inactivation (not tested) or incomplete penetrance.  Additionally, there is a loss of 
function variant in the gnomAD database of presumptively healthy individuals (allele count 
1/178,804) which raises the possibility of the rare case of incomplete penetrance 
(https://gnomad.broadinstitute.org accessed May 1, 2019).  Collectively from the 12 cases from 
the present study and medical literature with LOF variants in STAG2, only one individual is male 
and he is reported to have HPE (Aoi et al., 2019); the most likely conclusion is that LOF variants 
in STAG2 are lethal or result in the most severe phenotype (HPE).  Coincidentally, Mullegama et 
al. reported a patient with a STAG2 with an identical variant as in patient 2 (Figure 1), c.205 
C>T; p.Arg69* (Mullegama et al., 2017).  The patient in the Mullegama report had dysgenesis of 
the splenium of the corpus callosum and the patient in this study had semilobar HPE, showing 
that STAG2 loss of function variants are responsible for a spectrum of midline brain anomalies.   
 
SMC1A 
The other five individuals with X-linked HPE were all females (Patients 7-11; Table 3; Figure) 
with four truncating variants and one with a missense variant in SMC1A, a cohesin complex gene 
known to be associated Cornelia de Lange syndrome (CdLS) (Deardorff et al., 2007).  Variants 
in SMC1A account for 4-6% of individuals with CdLS (12-14 Jansen)(Ansari et al., 2014; Boyle 
et al., 2015; Yuan et al., 2015) and are most commonly missense and in-frame deletions 
(Huisman et al., 2013).  Four of five individuals in the present study have LOF variants; 
therefore, we have used 16 cases with LOF variants in SMC1A in the medical literature with 
phenotype information for comparison in Table 3 (Hoppman-Chaney et al., 2012; Goldstein et 
al., 2015; Lebrun et al., 2015; Jansen et al., 2016; Symonds et al., 2017).  The most severe 
phenotype in the LOF variants in the medical literature was holoprosencephaly found in 2 of 16 
individuals (Hoppman-Chaney et al., 2012; Symonds et al., 2017).  In both the present study and 
in the medical literature, when parents were available, all LOF variants were de novo and all 
individuals were females.  In addition to midline brain defects, the most striking phenotype is 
seizure disorders.  In the present study, 4 of 5 individuals had seizures and 15 of 16 in the 
medical literature.  In the largest study of 10 individuals with truncating variants in SMC1A, 9 of 
the 9 reporting seizures had severe drug resistant epilepsy (Symonds et al., 2017).  All 16 cases 
of the present study and medical literature had developmental delay.  Two individuals in the 
present study have facial characteristics consistent with mild CdLS, patients 9 and 10 both have 
synophrys and small hands.  In the largest study of LOF variants in SMC1A (Table 3), the 
authors report few phenotype characteristics consistent with CdLS (Symonds et al., 2017). 
 
RAD21 
Four variants were found in the two cohesin complex genes that are not X-linked, three were in 
the gene RAD21.  The three RAD21 variants (Patient 12 and 13; Table 4) were loss of function; 
interestingly, patient 12 with the c.1548delinsTC p.(Glu518Argfs*19) variant in RAD21 is an 
inherited variant in this study with the father having the same variant, synophrys, and a 
submucous cleft palate.  The three LOF variants in the present study are compared to LOF and 
deletions involving RAD21 in the medical literature (Wuyts et al., 2002; McBrien et al., 2008; 
Deardorff et al., 2012b; Minor et al., 2014; Boyle et al., 2017).  A much higher fraction of LOF 
variants are inherited compared to STAG2 and SMC1A:  present study 1 (1/1) and in the medical 
literature, 2 of 5 (when parents where available).  Both the present study and the medical 
literature presented individuals with cardinal features of CdLS (Kline et al., 2018), including:  
synophrys or thick eyebrows in 7/9, short or upturned nose in 4/9, long philtrum 4/9, and 
microcephaly in 5/9. 
 
SMC3 
The fourth non-X linked gene is SMC3 and the SMC3 variant (Patient 15; Table 5) was a de novo 
in-frame deletion which is likely pathogenic (Richards et al., 2015).  In Table 5, we compare to 
the largest most comprehensive series of individuals with variants in SMC3 (n=16) (Gil-
Rodriguez et al., 2015).  The present study found an inframe deletion in SMC3 in a fetus with 
semilobar HPE, median cleft lip, tetralogy of Fallot, hypospadias, anal atresia and limb 
anomalies.   Gil-Rodríguez et al. found two of their study participants to have midline brain 
malformations:  corpus callosum dysgenesis (2/11) and no cases of holoprosencephaly (Gil-
Rodriguez et al., 2015).  Based on reviewing the present study’s case and the cohort presented by 
Gil-Rodríguez et al. intellectual disability (13/13) and congenital heart disease (10/17) were 
prevalent.  The facial features are difficult to characterize due to the early gestation in the present 
study (Figure); however, Gil-Rodríguez et al. found a majority of cases to have facial features 
consistent with CdLS (Table).     
 
Mouse in situ hybridization 
As a control, we first examined the expression of Shh (Figure 2), a gene with a well-
characterized expression domain and role in forebrain patterning and HPE (Chiang et al., 1996; 
Solomon et al., 2012; Hong et al., 2016).  Expression of Shh is restricted to the ventromedial 
neuroectoderm (Figure 2) as previously described (Echelard et al., 1993).  Both Smc1a and Stag2 
are also strongly detected in the anterior neural folds with expression observed in both the 
neuroectoderm and adjacent mesenchyme (Figure 2).  The specificity of the observed expression 
domains for these genes is supported by the absence of staining in extra-embryonic membrane 
tissue lateral to the neural folds.  
 
Gene expression studies in human neural progenitor cells 
As noted in the methods section, we analyzed the expression level of genes known to be 
involved in HPE pathways with RT-qPCR which include SHH, SIX3, FGFR1, GLI2, ZIC2, 
GLI2, SMAD3 and DISP1.  SHH, SIX3, ZIC2, and FGFR1 were chosen as variants in these genes 
are known to cause HPE (Kruszka et al., 2018; Kruszka, 2018).  DISP1 is part of the sonic 
hedgehog pathway and has been associated with HPE (Roessler et al., 2009; Dubourg et al., 
2016); also part of the sonic hedgehog pathway, GLI2 is an often HPE tested gene that is 
associated with HPE spectrum anomalies including pituitary insufficiency, midface hypoplasia, 
hypotelorism, and cleft lip/palate (Kruszka et al., 2018).  Although not know to contain driver 
mutations associated with HPE, SMAD3 physically interacts with ZIC2 and controls 
transcription in a NODAL dependent manner and variant forms of ZIC2 associated with HPE in 
humans and the mouse have difficulty with SMAD-dependent transcription, making SMAD3 of 
interest (Houtmeyers et al., 2016).  Compared to controls, SMC1A knockdown in human neural 
stems cells resulted in significantly increased expression in GLI2 (P < 0.01), ZIC2 (P < 0.05), and 
SMAD3 (P < 0.05) (Figure 3).  For STAG2 knockdown (Figure 4), significantly increased 
expression was seen in ZIC2 (P < 0.0001) and FGFR1 (P < 0.01).  Thus, there was over 
expression in ZIC2 from knockdown of both SMC1A and STAG2.  Similar to a previous 
experiment (Cotney et al., 2015), SHH and SIX3 expression was undetectable in H9-derived 
human neural stem cells (ThermoFisher/Invitrogen, #N7800-100). 
 
Discussion 
Holoprosencephaly research and clinical care has focused on sonic hedgehog pathway and the 
genes SHH, ZIC2, and SIX3 for the last two decades (Roessler and Muenke, 2010; Roessler et 
al., 2018).  This study introduces new genes in the cohesin complex as important components of 
early forebrain division and the holoprosencephaly spectrum.  Evaluating the holoprosencephaly 
study at the National Human Genome Research Institute with whole exome sequencing, five of 
277 probands were identified with variants in cohesin complex genes.  Ten additional individuals 
with holoprosencephaly were identified from other institutions.  Eleven of the fifteen individuals 
had variants in the X-linked genes STAG2 and SMC1A.  STAG2 has only recently been 
associated with human disease (Mullegama et al., 2017; Soardi et al., 2017; Aoi et al., 2019; 
Mullegama et al., 2019; Yuan et al., 2019).  A small number of cases with cohesin complex HPE 
have been reported in the medical literature in the past: two HPE cases with LOF variants in 
STAG2 (Aoi et al., 2019; Yuan et al., 2019), two cases associated with SMC1A (Hoppman-
Chaney et al., 2012; Symonds et al., 2017), and no HPE cases have been reported that we are 
aware in RAD21 and SMC3.  Knowing that all individuals with CdLS have not had brain 
imaging, the incidence of HPE associated with cohesinopathy genes may be more common than 
previously reported. 
 
Interestingly, the 11 individuals in this study with STAG2 and SMC1A variants are females, thus 
we propose that loss-of-function variants in the X-linked cohesin genes are usually lethal in 
males; certainly there are possible exceptions in males including mosaicism, 47,XXY, and gene 
duplications.  Notably, STAG2 undergoes complete X inactivation and SMC1A undergoes partial 
X-inactivation (Cotton et al., 2013).  For Patient 2 with a STAG2 nonsense variant (c.205C>T 
p.(Arg69*), X-inactivation studies were consistent with random X-inactivation, implying that 
haploinsufficiency is required for the HPE phenotype in STAG2.  The one exception to LOF in 
STAG2 and SMC1A is Patient 9; who had a missense variant (Table 1) is located in the conserved 
second coiled-coil domain and is likely pathogenic (Richards et al., 2015).  Based on the loss of 
function variants in SMC1A in the other four individuals in this report, we hypothesize that the 
SMC1A variant (c.2683C>G (p. Arg895Gly)) has a loss of function variant or a dominant 
negative effect.  To evaluate X-linked inheritance from our HPE registry, we performed a 
binomial distribution on 700 individuals with HPE.  Of these 700 individuals, 409 were female 
(p= 0.000005).  If we subtract individuals with known pathogenic variants in SHH, SIX3, and 
ZIC2, there are 645 individuals, of whom, 378 are female (p= 0.000015).  Although STAG2 and 
SMC1A variation most likely does not explain this significant trend towards female sex in our 
registry, X-linked dominant inheritance likely plays an important role. 
 
Previous study has shown that antagonizing the hedgehog signaling pathway between gestational 
days 7.0 and 8.25 of mouse development (between 15 and 18.75 days of human gestation) results 
in holoprosencephaly (Heyne et al., 2015a).  Since forebrain patterning genes are expected to be 
expressed in the prosencephalic neural folds during primary neurulation (Geng and Oliver, 
2009), we assessed expression of cohesin complex genes during this critical period for 
holoprosencephaly in the mouse. The finding that both Smc1a and Stag2 are expressed in the 
prosencephalic neural folds complements the human genetic evidence in this study and supports 
the role of cohesion complex genes in forebrain morphogenesis.  Being expressed in both the 
neuroectoderm and adjacent mesenchyme suggests that the cohesion complex may interact with 
other critical regulators of forebrain patterning and HPE pathogenesis.   
 
To further elucidate the relationship between forebrain division in early embryogenesis and the 
cohesin complex, we knocked down cohesin complex gene expression in human progenitor cells 
and measured canonical HPE gene expression.  Upregulation in gene expression was seen in 
GLI2, ZIC2 and SMAD3 for SMC1A knockdown (Figure 3), and ZIC2 and FGFR1 for STAG2 
knockdown (Figure 4).  Loss of function in ZIC2 has been associated with HPE in the past and 
the mechanism of increased expression in SMC1A and STAG2 knockdown human neural 
progenitor cells is not completely clear.  In the mouse model, loss of function of Zic2 results in 
the failure to activate specific genes in the mid-gastrula node including Foxa2 which is required 
to activate Shh in the prechordal plate (Warr et al., 2008).  There is evidence in the Xenopus that 
over expression of zic2 may contribute depletion of foxa2 in the Spemann organizer 
(Houtmeyers et al., 2016).  Overexpression by injection of zic2 mRNA into Xenopus embryos at 
the 4-8 cell stage resulted in reduced foxa2 expression (Houtmeyers et al., 2016).  SMAD3 is 
upregulated in SMC1A knockdown which is of interest as SMAD3 and ZIC2 physically interact 
with each other in cell culture (A549 cells) to occupy a binding site in the promoter region of 
FOXA2 (Houtmeyers et al., 2016).  FGFR1 expression increased in STAG2 knockdown neural 
progenitor cells.  FGFR1 variants are associated with Hartsfield syndrome which has 
holoprosencephaly and split hands and feet as phenotype elements.  It is unclear how 
overexpression of FGFR1 is related to holoprosencephaly as the mechanism of FGFR1 in HPE is 
a dominant negative effect (Hong et al., 2016).  GLI2 is overexpressed in the SMC1A 
knockdown neural progenitor cells. GLI2 is both a transcriptional activator and repressor in the 
sonic hedgehog pathway (Sasaki et al., 1999)  and although it does not cause holoprosencephaly, 
loss of function variants in GLI2 are associated with Culler-Jones syndrome which presents with 
hypopituitarism, polydactyly, and facial features often found in holoprosencephaly (Kruszka et 
al., 2018). 
 
In conclusion, we present 15 patients with holoprosencephaly spectrum malformations who have  
variants in cohesin complex genes STAG2, SMC1A, SMC3, and RAD21.  Although the precise 
mechanism of abnormal forebrain development is unknown in loss of function variants in 
cohesin complex genes, Stag2 and Smc1a are expressed in neural fold at the critical time of 
forebrain division in the mouse model.  Additionally, we show that knockdown of STAG2 and 
SMC1A in human neural progenitor cells perturbs known HPE genes.  Currently, there are no 
cohesin complex or X-linked genes that are commonly tested for in individuals with 
holoprosencephaly (Kruszka et al., 2018).  This report of X-linked and cohesin complex 
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Figure 1.  Patient images referenced from Table 1:  A) Patient 3 with alobar HPE and a 
c.436C>T p.(Arg146*) variant in STAG2;  B) Patient 5 with microform HPE and a 
c.2898_2899del p.(Glu968Serfs*15) in STAG2; C) Patient 2 with semilobar HPE and a 
c.205C>T p.(Arg69*) variant in STAG2; D) Patient 9 with semilobar HPE and a c.2683C>G (p. 
Arg895Gly) variant in SMC1A ; E)  Patient 7 with MIHV HPE and a c.3285+1G>C variant in 
SMC1A; F) Patient 8 with microform HPE and a c.1495C>T:p.(Arg499*) variant in SMC1A; G) 
Patient 15 with semilobar HPE and a SMC3 variant c.1138_1152del p.(Gly380_Gln384del).  
HPE (holoprosencephaly); MIHV (middle interhemispheric variant) 
 
Figure 2.  Gestational day (GD) 8.25 mouse embryos were stained by in situ hybridization to 
determine gene expression patterns.  A ventral view is shown for whole mounts.  Transverse 
sections through the prosencephalic neural folds (at the level of the dashed line in schematic) 
were stained to visualize gene expression in specific cellular compartments.  nf – neural folds, h 
– heart, ne – neuroectoderm, hm – head mesenchyme, eem – extra-embryonic membranes.  Scale 
bar = 100 µm.   
 
Figure 3. Neural stem cells expressing ShSMC1A or Non Silencing control (NS Ctrl) are 
analyzed by RT-qPCR  48h after transfection. Gene expression results are shown for genes 
previously described as genetic causes of HPE. Results are expressed over SNAPIN. The mean of 
the signals obtained from three independent experiments is shown.  The error bars represent the 
SD. Asterisk indicates statistical significance (p value) as evaluated by Unpaired Two Tailed t-
test analysis. Non statistically significant p values are indicated in brackets.  
*= P < 0.05; **= P < 0.01.  
 
Figure 4. Neural stem cells expressing ShSTAG2 or Non Silencing control (NS Ctrl) are analyzed 
by RT-qPCR  72h after transfection. Gene expression results are shown for genes previously 
described as genetic causes of HPE  Gene expression results are expressed over SNAPIN. The 
mean of the signals obtained from three independent experiments is shown.  The error bars 
represent the SD. Asterisk indicates statistical significance (p value) as evaluated by Unpaired 
Two Tailed t-test analysis. Non statistically significant p values are indicated in brackets.  
























































































































de novo 35 20 months semilobar 










































MIHV, middle interhemispheric variant type holoprosencephaly; CADD, Combined Annotation-Dependent Depletion 
Table 2.  Phenotype details of individuals with loss of function variants in STAG2. 
 Present Study 
Mullegama et 
al. 2016 
Aoi et al. 2019 Yuan et al. 2019 



























inheritance de novo de novo singleton maternal de novo de novo de novo de novo de novo de novo de novo de novo 
sex female female female female female female female male female female female female 


































































microcephaly + + + severe + - + NR - - + + 
ear anomalies 
and hearing 























































c left heart 
NR NR 
growth delay NR + NA NA + -  NR short stature - + + 
limb 
anomalies 












al reflux and 
has a G-tube 
and Nissen 
fundoplication 









 seizure disorder 
Double outlet right ventricle, DORV; holoprosencephaly, HPE; magnetic resonance imaging, MRI ; NA non-applicable; NR, not reported; 
aautopsy finding 
Table 3. Phenotype details of individuals with variants in SMC1A. 
 Present Study Symonds et al., 
2017 
Jansen et al., 
2016 
Goldstein 
et al., 2015 

























8.2kb deletion in 
SMC1A; 
45,X[7]/46,XX[23] 
inheritance de novo singleton de novo de novo de novo 
de novo 10/10 de novo 2/2 de novo 
2/2 
de novo de novo 
sex female female female female female female 10/10 female 2/2 female 2/2 female female 
age 
15 months 16.5 months 6 years 3 years 20 months 11 months – 14 
years 
14-46 years 3-4 years 7 years 10 years 
brain MRI MIHV HPE 
triventricular 
ectasia 
semilobar/lobar HPE semilobar HPE semilobar HPE 
semilobar HPE 
1/10; thin corpus 


















+ + + + + 10/10 2/2 2/2 + + 
craniofacial 
anomalies 

















cleft palate 2/10 cleft palate 
1/2 
0/2 retrognathia skull asymmetry with 
right-sided flattening, 
prominent metopic 
suture, and bitemporal 
narrowing 
microcephaly 
+ + + + + average Z-score -
3.0 (9/9) 
1/2 0/2 + + 
ear anomalies 
and hearing 











NR NR NR NR bifid thoracic 
vertebrae 2/10 
Scoliosis 2/2 0 - T7-T12 butterfly 




- - NR - patent foramen 
ovale 
4/10 0/2 0/2 - tetralogy of Fallot 
growth delay 
+ + - + NR average Z-score -
3.0 (9/9) 
2/2 1/2 + + 
limb 
anomalies 
NR small hands small hands; 
proximal implant of 
thumbs 









multiple minor limb 
anomalies 
other 





















Holoprosencephaly, HPE: middle interhemispheric variant, MIHV; not reported, NR; 
Table 4.  Phenotype details of individuals with loss of function variants in RAD21. 
 Present Study Boyle et al., 2017 Minor et al., 2014 Deardorff et al., 2012 








































Chaney et al., 
2012)unknown 
unknown maternal maternal 




de novo NR de novo de novo
sex female male male female male male male NR male male 
age 7 years 14 years 2 years 26 years 3 years 12 years 7 years NR 26 months 18 years
brain MRI MIHV 
HPE 
nonspecified 



















long philtrum, thin 
upper lip 
vermillion, short 
nose with upturned 































microcephaly NR +  + - + + - + - 
ear anomalies 
and hearing 






- - NR - 
vertebral 
anomalies 













growth delay    - + - - + - - 
limb 
anomalies 
   
5th finger 
clinodactyly 
minor hand and 
feet anomalies 
minor hand and 
feet anomalies 
minor hand and 
feet anomalies 
proximal thumb 


















aFather of proband is affected with synophrys, and a submucous cleft palate 
bMother affected with microcephaly and facial features consistent with CdLS 
cRAD21 is only cohesin complex gene in minimal overlapping interval (RAD21, EIF3H, UTP23, SLC30A8, MED30, EXT1, RAD21-AS1, AARD)  
 
Table 5. 
 Present Study Gil-Rodríguez et al., 2015 
 Patient 15 n=16 
variant 
c.1138_1152del p.(Gly380_Gln384del) missense (9/16); inframe deletions/duplications (6/16); 
nonsense (1/16) 
inheritance de novo de novo (10/10) 
sex male female 7/16 
age fetus NR 
brain imaging semilobar HPE corpus callosum dysgenesis (2/11);  porencephalic cyst (1/11) 
developmental delay NA intellectual disability (13/13) 
craniofacial anomalies 
median cleft lip cleft palate 1/14; synophrys (11/15); thick eyebrows (9/13); 
anteverted nostrils (8/14); thin upper lip vermilion (13/16) 
microcephaly NR 6/12 
ear anomalies and hearing NR low set ears (6/11); hearing loss 7/13 
vertebral anomalies NR butterfly vertebrae (1/12); scoliosis (1/12) 
congenital heart disease tetralogy of Fallot 9/16 
growth delay NA height Z-score < -3.0 (6/16);  weight Z-score < -3.0 (5/16) 
limb anomalies 
hand/feet cutaneous syndactyly; ulnar deviation of 2nd digit of 
hands bilaterally; proximally set thumbs 
small hands (11/14); small feet (11/13); proximally set thumbs 
(12/16) 
other hypospadias; anal atresia seizures (3/12) 
Holoprosencephaly, HPE; non-applicable, NA 
 
 
